Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Impact of perinatal antibiotics on the generation of protective mammary IgA

Award Number: F31HD121285
ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 12/02/2026
PERIOD OF PERFORMANCE END DATE: 12/01/2029

Group Awards By:

View Award Description

Impact of perinatal antibiotics on the generation of protective mammary IgA - Project Summary/Abstract Neonates are a particularly vulnerable population due to the change in their environment at birth, the subsequent microbial colonization that results, and the relative immaturity of their immune systems compared to adults. Of importance is the fact that neonates, especially those of very low birth weight born to patients experiencing premature birth, are at an increased risk of developing sepsis resulting from a systemic infection. Though published data has shown the benefit of maternal antibiotics which reduce the risk of early-onset sepsis from vertical bacterial transmission, the risk of late-onset sepsis (LOS) is increased, highlighting the need to further understand how maternal antibiotics might impact neonatal outcomes. Neonatal immunological immaturity and its ramifications are mitigated through maternal measures including transplacental IgG transfer during late pregnancy and through immunoglobulin (Ig) conferred in breastmilk. In the post-birth period breastmilk becomes the only source of protective antibody with IgA, the antibody found most abundantly at mucosal surfaces, accounting for the highest concentration of Ig. Preliminary data from an ongoing collaboration has shown that IgA concentrations in human breastmilk is decreased following perinatal antibiotic administration in patients. Similarly, our lab has shown that IgA is also decreased in the breastmilk of lactating mice that were given antibiotics for one week prior to delivery, underscoring the potential perturbation of processes contributing to the generation of IgA. Mammary IgA is predominantly produced from plasma cells that trafficked to this site after generation in the maternal intestine, suggesting antibiotic-mediated perturbation of the perinatal maternal microbiome disrupts mammary IgA. Furthermore, we hypothesize that the maternal gut microbiota drives the generation of pathogen-specific IgA in late pregnancy that serves as protection from intestinal pathogens in neonates. To test this hypothesis, we have devised two aims to first, evaluate the contribution of the maternal microbiota in late pregnancy in the generation of mammary IgA and second, to assess the role of mammary IgA in protecting neonates from intestinal pathogens. We will utilize a model of perinatal antibiotic administration in conjunction with our established model of LOS in both wildtype C57BL6 mice and IgA deficient mice in a C57BL6 background to address these aims. This work is of significant clinical importance due to the need to better understand maternal protections conferred to neonates during pregnancy and lactation. In addition, this work could contribute to clinical decisions by informing the implementation of antibiotic regimens during pregnancy with the potential for informing regimen adjustments to better account for long-term effects of perinatal maternal antibiotics.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $50,114 )
2026	2026	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Child Health and Human Development Extramural Research	001	1	9/3/2026	NEW	$0
2026	2026	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Child Health and Human Development Extramural Research	000	1	9/3/2026	NEW	$50,114
														Subtotal = $50,114

Grand Total All Awards = $50,114

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Impact of perinatal antibiotics on the generation of protective mammary IgA

Award Number: F31HD121285

ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 12/02/2026

PERIOD OF PERFORMANCE END DATE: 12/01/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer